Benefits of Microdosing Semaglutide: A Gentler GLP1 Path to Weight, Mood, and Hormone Balance GLP1 medications have taken the wellness world by storm, promising rapid weight loss and metabolic transformation
It went into a real Phase 2/3 Alzheimers trial, LIFT-AD, with 554 patients enrolled (NCT04488419), the primary efficacy analysis pre-specified in the 312 of them not taking another Alzheimers drug
Skin appears more luminous, tone looks more uniform, and texture may feel smoother
Prevalence and risk factors for secondary hyperparathyroidism (SHPT) in patients undergoing bariatric surgery
In 2014, a systematic review and metaanalysis of 82 followup studies on the body mass index (BMI) and survival of women with breast cancer found that obesity was consistently associated with an increased risk of total mortality and breast cancer mortality (41% and 35% respectively) compared with normalweight women [15]
Market Health Understanding the tension between investment, access, and market demand Venture capital trends Investigating development and manufacturing supply chains Interacting with regulatory bodies from legislators to state licensing boards Patient Safety Discussing the different sources of GLP1s and their implications on consumer choice, market health, and patient safety Traditional prescriptions Telehealth providers Peptide sellers Other gray market sources Describing the different online consumer marketing and prescribing workflows with Telehealth providers and what factors relate to patient safety concerns Assessing current guidelines for patient follow-up and prescription timelines Telehealth vs
